Descriptor English: | Debrisoquin | ||||
Descriptor Spanish: |
Debrisoquina
| ||||
Descriptor Portuguese: | Debrisoquina | ||||
Descriptor French: | Débrisoquine | ||||
Entry term(s): |
Debrisoquine Tendor |
||||
Tree number(s): |
D03.633.100.531.205 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D003647 | ||||
Scope note: | An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism. |
||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
Pharm Action: |
Antihypertensive Agents Sympatholytics Adrenergic Agents |
||||
Registry Number: | X31CDK040E | ||||
CAS Type 1 Name: | 2(1H)-Isoquinolinecarboximidamide, 3,4-dihydro- | ||||
Previous Indexing: |
Antihypertensive Agents (1966-1972) Isoquinolines (1969-1972) |
||||
Public MeSH Note: | 91; was see under ISOQUINOLINES 1973-90 |
||||
History Note: | 91(73); was see under ISOQUINOLINES 1973-90 |
||||
DeCS ID: | 3665 | ||||
Unique ID: | D003647 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 1991/01/01 | ||||
Date of Entry: | 1999/01/01 | ||||
Revision Date: | 2016/05/28 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Debrisoquin
- Preferred
Tendor
- Narrower
Concept UI |
M0005709 |
Scope note | An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism. |
Preferred term | Debrisoquin |
Entry term(s) |
Debrisoquine |
Concept UI |
M0005710 |
Preferred term | Tendor |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey